Compare Davita Inc (DVA) vs Howmet Aerospace Inc (HWM) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Davita Inc vs Howmet Aerospace Inc — how do they compare? Davita Inc trades at $180.24 (market cap $11.38B), while Howmet Aerospace Inc trades at $284.81 (market cap $112.20B). The key difference: Howmet Aerospace Inc is far larger — about 9.9× Davita Inc's market cap, and Howmet Aerospace Inc pays a 0.2% dividend while Davita Inc pays none. Which is the better fit depends on your goals.
| DVA | HWM | |
|---|---|---|
Market Cap | $11.38B | $112.20B |
Sector | Health | Industrials |
52-Week High | $240.96 | $291.28 |
52-Week Low | $103.87 | $171.00 |
Enterprise Value | $24.10B | $116.30B |
Dividend Yield | — | 0.2% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
DaVita (DVA) trades at $180.25, down 1.87% amid mixed signals. The stock shows strong earnings momentum with three consecutive quarterly beats (Q4 2025-Q2 2026) but faces margin pressure. Technical indicators are conflicted with a bullish overall signal but bearish moving averages. Revenue growth remains steady, climbing from $11.6B in 2022 to $13.6B in 2025, though net income margin fluctuated between 4.82% and 7.3% over the same period.
The outlook is cautiously optimistic with a $232.25 consensus price target offering 29% upside. Key risks include reimbursement pressure and high debt levels (debt-to-asset ratio of 65.55% in 2025). Analyst sentiment leans neutral (56.52% Hold) despite recent earnings strength, reflecting concerns about payer mix and margin sustainability.
Howmet Aerospace (HWM) trades at $283.94, up 0.08% with strong bullish momentum following consecutive earnings beats. The stock shows robust fundamentals with Q2 2026 EPS of $1.33 beating estimates by 7.3%, driven by 24% revenue growth in aerospace and defense markets. Technical indicators signal bullish momentum with the current price above key support levels. The company raised full-year 2026 guidance, reflecting confidence in continued demand across commercial aerospace and gas turbine segments.
Outlook remains positive with 84% analyst buy ratings and $334.63 consensus price target suggesting 18% upside. Key risks include execution of capacity expansion plans and potential supply chain constraints. The combination of strong earnings momentum, raised guidance, and institutional support positions HWM for continued growth, though investors should monitor Q3 2026 results due for confirmation of guidance sustainability.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Davita Inc
DaVita is the largest provider of dialysis services in the United States, boasting market share that eclipses 35% when measured by both patients and clinics. The firm operates over 3,100 facilities worldwide, mostly in the U.S., and treats over 240,000 patients globally each year. Government payers dominate U.S. dialysis reimbursement. DaVita receives approximately 69% of U.S. sales at government (primarily Medicare) reimbursement rates, with the remaining 31% coming from commercial insurers. However, while commercial insurers represented only about 10% of the U.S. patients treated, they represent nearly all of the profits generated by DaVita in the U.S. dialysis business.
Read more on DVA →About Howmet Aerospace Inc
Howmet Aerospace provides advanced engineered solutions for the aerospace and transportation industries. It specializes in jet engine components, aerospace fastening systems, and forged aluminum wheels.
Read more on HWM →
